Genetic polymorphisms are not associated with energy intake one year after Roux‐Y gastric bypass (RYGB) in women

2021 ◽  
Author(s):  
Patrícia Fatima Sousa Novais ◽  
Alex Harley Crisp ◽  
Vania Aparecida Leandro‐Merhi ◽  
Renata Maria Galvão Cintra ◽  
Irineu Rasera ◽  
...  
Keyword(s):  
Gastric Bypass ◽  
Genetic Polymorphisms ◽  
Energy Intake ◽  
One Year

TRANSORAL OUTLET REDUCTION FOR WEIGHT REGAIN AFTER GASTRIC BYPASS: ONE YEAR FOLLOW-UP

2019 ◽  
Author(s):  
V Bove ◽  
I Boškoski ◽  
R Landi ◽  
G Gibiino ◽  
L Laterza ◽  
...  
Keyword(s):  
Gastric Bypass ◽  
Weight Regain ◽  
One Year

Type 2 diabetes remission one year after bariatric surgery - a comparison between vertical sleeve gastrectomy and gastric bypass

2018 ◽  
Author(s):  
Ines Ferreira Barros ◽  
Silvia Paredes ◽  
Fernando Manso ◽  
Costa Jose Manuel Maia da ◽  
Aline Fernandes ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Bariatric Surgery ◽  
Gastric Bypass ◽  
Sleeve Gastrectomy ◽  
Diabetes Remission ◽  
Vertical Sleeve Gastrectomy ◽  
Type 2 Diabetes Remission ◽  
One Year

78-OR: Glycaemia, Beta-Cell Function, and Incretin Hormones Post-OGTT One Year after Gastric Bypass and Sleeve Gastrectomy in Patients with Morbid Obesity and Type 2 Diabetes: An RCT (Oseberg Study)

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 78-OR
Author(s):  
FARHAT FATIMA ◽  
JØRAN HJELMESÆTH ◽  
KARE I. BIRKELAND ◽  
HANNE L. GULSETH ◽  
JENS K. HERTEL ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Morbid Obesity ◽  
Gastric Bypass ◽  
Sleeve Gastrectomy ◽  
Beta Cell ◽  
Beta Cell Function ◽  
Cell Function ◽  
Incretin Hormones ◽  
One Year

Genetic polymorphisms and cardiovascular outcomes in Chinese patients undergoing PCI and treated with clopidogrel and aspirin

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
K Xu ◽  
L Ying ◽  
J Chen ◽  
L Xu ◽  
J Li ◽  
...  
Keyword(s):  
Platelet Aggregation ◽  
Genetic Polymorphisms ◽  
Light Transmission ◽  
Left Ventricular ◽  
Cardiovascular Outcomes ◽  
Chinese Patients ◽  
Left Ventricular Ejection ◽  
Funding Source ◽  
Ventricular Ejection Fraction ◽  
One Year

Abstract Background Genetic polymorphisms of key proteins involved in clopidogrel absorption, metabolism, and action may contribute to variability in platelet inhibition in patients undergoing percutaneous coronary intervention (PCI), but their impacts on cardiovascular outcomes remain unclear. Purpose To examine the associations between genetic polymorphisms and cardiovascular outcomes in Chinese patients undergoing PCI and treated with clopidogrel and aspirin. Methods This prospective cohort study consecutively enrolled 2,453 post-PCI patients treated with clopidogrel and aspirin. Adenosine diphosphate-induced platelet aggregation was measured by light transmission aggregometry. A total of 40 single nucleotide polymorphisms (SNPs) of 18 genes selected according to published studies were investigated using an improved multiplex ligation detection reaction technique. The primary outcome was major adverse cardiovascular event (MACE), the composite of cardiovascular death, non-fatal myocardial infarction (MI), and ischemic stroke within one year after PCI. Results We restricted the analyses to the first 1,452 patients who had finished one-year follow-up and complete data on genotyping and platelet aggregation. 44 (3.03%) patients suffered MACE. Among the 40 SNPs, only the A-allele carriers of CYP2C19*2 had a significant higher risk of MACE (adjusted HR 2.05; 95% CI, 1.01–4.19; p=0.048) and platelet aggregation than non-A-carriers after adjusting age, sex, MI presentation, and left ventricular ejection fraction. CYP2C19*3, CYP2B6 rs3745274, and PEAR1 rs12041331 variants were also significantly associated with platelet aggregation (all p<0.05) but not with MACE at 1 year. Conclusion About 54.2% of Chinese patients with PCI were A-allele carriers of CYP2C19*2, who face a two-fold higher risk of MACE than non-A-allele carriers in Chinese patients after PCI. It would help identify low clopidogrel responders and optimize antiplatelet therapy before drug administration. Figure 1 Funding Acknowledgement Type of funding source: Public grant(s) – National budget only. Main funding source(s): National Natural Science Funding of China

Weight loss one year after laparoscopic roux-en-Y gastric bypass is not dependent on the type of gastrojejunal anastomosis

2021 ◽  
Author(s):  
Fernando Munoz-Flores ◽  
Jorge Humberto Rodriguez-Quintero ◽  
David Pechman ◽  
Collin Creange ◽  
Ariela Zenilman ◽  
...  
Keyword(s):  
Weight Loss ◽  
Gastric Bypass ◽  
Gastrojejunal Anastomosis ◽  
One Year

scholarly journals Variation of Binge Eating One Year after Roux-en-Y Gastric Bypass and Its Relationship with Excess Weight Loss

PLoS ONE ◽  
2016 ◽  
Vol 11 (12) ◽  
pp. e0167577 ◽  
Author(s):  
Luciano Billodre Luiz ◽  
César Luis de Souza Brito ◽  
Letícia Manoel Debon ◽  
Lívia Nora Brandalise ◽  
Juliana Tainski de Azevedo ◽  
...  
Keyword(s):  
Weight Loss ◽  
Gastric Bypass ◽  
Binge Eating ◽  
Excess Weight Loss ◽  
Excess Weight ◽  
One Year

One-year human experience with a novel endoluminal, endoscopic gastric bypass sleeve for morbid obesity

2015 ◽  
Vol 29 (11) ◽  
pp. 3298-3303 ◽  
Author(s):  
Bryan J. Sandler ◽  
Roberto Rumbaut ◽  
C. Paul Swain ◽  
Gustavo Torres ◽  
Luis Morales ◽  
...  
Keyword(s):  
Morbid Obesity ◽  
Gastric Bypass ◽  
Human Experience ◽  
One Year

Energy Intake and Food Habits between Weight Maintainers and Regainers, Five Years after Roux-en-Y Gastric Bypass

2016 ◽  
Vol 77 (4) ◽  
pp. 195-198 ◽  
Author(s):  
Ryan E. R. Reid ◽  
Ekaterina Oparina ◽  
Hugues Plourde ◽  
Ross E. Andersen
Keyword(s):  
Weight Loss ◽  
Gastric Bypass ◽  
Alcohol Consumption ◽  
Energy Intake ◽  
Dietary Assessment ◽  
Active Role ◽  
Registered Dietitian ◽  
Term Care ◽  
Post Surgery ◽  
Complex Population

We explored differences in dietary behaviours, energy, and macronutrient intake among individuals who had regained or maintained weight loss 5 or more years after Roux-en-Y gastric bypass (RYGB). This study assessed 27 adults who underwent RYGB an average of 12.1 ± 3.7 years before this study was conducted. Dietary assessment was performed using 3-day food records. Daily energy intake (kcal), protein (g), carbohydrate (g), fat (g), and alcohol intake (g) were computed using the ESHA’s Food Processor®. Participants were classified by percent weight loss, maintainers (≥38 %), and regainers (≤30 %). Daily carbohydrate consumption was greater in regainers (222 ± 84.3 g) compared with maintainers (162 ± 67.5 g), (P < 0.05). Thirty-seven percent of participants were not consuming the recommended amount of protein and 26% reported never taking vitamin supplements after surgery. Alcohol consumption was higher among regainers (18.5 ± 30.9 g) compared with maintainers (2.6 ± 6.5 g), (P < 0.05). Finally, 74% of the participants reported no contact with a Registered Dietitian, whereas 78 % were in contact with a health care professional once a year post-surgery. Differences were seen in carbohydrate intake and alcohol consumption between weight maintainers and regainers. These data suggest dietitians need to play a more active role in the long-term care of this medically complex population.

Comparison of results after one year between sleeve gastrectomy and gastric bypass in patients with BMI≥50 kg/m²

2015 ◽  
Vol 11 (4) ◽  
pp. 785-790 ◽  
Author(s):  
Jérémie Thereaux ◽  
Nicola Corigliano ◽  
Christine Poitou ◽  
Jean-Michel Oppert ◽  
Sebastien Czernichow ◽  
...  
Keyword(s):  
Gastric Bypass ◽  
Sleeve Gastrectomy ◽  
Comparison Of Results ◽  
One Year
Sign in / Sign up

Export Citation Format

Share Document